The MarketWatch News Department was not involved in the creation of this content. -- Potential first-in-class, and industry-leading DNA polymerase Theta (Pol ) inhibitor, ART6043 demonstrated an ...
Applied DNA Sciences (APDN) announced that the State Institute for Drug Control of the Czech Republic approved an application for a Phase I clinical trial of an investigational CD123-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results